Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors

Dateline City:
KENILWORTH, N.J.KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
today announced that Dr. John H. Noseworthy, president and chief
executive officer of Mayo Clinic, has been nominated to stand for
election to the company ’s board of directors. The annual election of Dr.
Noseworthy and the other directors will take place in connection with
Merck’s Annual Meeting of Shareholders on May 23, 2017. With the
proposed addition of Dr. Noseworthy, and the planned retirement of C.Language:
EnglishContact: MerckMedia:Tracy Ogden, 215-370-5597orInvestors:Teri Loxam, 908-740-1986Ticker Slug:Ticker:MRKExchange:NYSE
@Merckread more

Source: Merck.com - Corporate News - April 10, 2017 Category: Pharmaceuticals Tags: Corporate News Latest News #Merck #MRK $MRK MSD NYSE:MRK Source Type: news